The relationship between calcium and vitamin D nutritional status and bone health represents one of the most thoroughly established and clinically consequential nutritional determinants of skeletal integrity across the human lifespan, from the calcium-dependent mineralization of bone during the childhood and adolescent years of peak bone mass accumulation through the maintenance of adult bone density and the prevention of the accelerated bone loss that leads to osteoporosis and fracture in later life. Calcium and vitamin D function as an inseparable nutritional partnership in bone metabolism, with vitamin D being required for the intestinal absorption of dietary calcium and the renal reabsorption of filtered calcium that together determine how much dietary calcium actually reaches the systemic circulation for delivery to bone, while calcium provides the primary mineral substrate for the hydroxyapatite crystals that give bone its rigidity and compressive strength. Deficiency of either nutrient individually, or of both together as is extraordinarily common in older adults worldwide, impairs bone mineralization, increases the physiological stimulus to parathyroid hormone secretion, accelerates bone resorption, and ultimately reduces bone mineral density in the direction of osteoporosis and fracture risk.
The global prevalence of calcium and vitamin D insufficiency is remarkable in its magnitude and its distribution across all demographic groups, including populations in which these nutritional deficiencies might not be intuitively expected. Calcium intake below recommended levels is estimated to affect more than three billion people worldwide, with low-income populations in sub-Saharan Africa and South and Southeast Asia particularly affected by the low dairy consumption and limited access to other calcium-rich foods that produce severe calcium deficiency in some regions. Vitamin D insufficiency, defined as serum 25-hydroxyvitamin D below fifty nanomoles per liter, affects an estimated one billion people worldwide across all geographic regions, including populations in sun-rich tropical countries whose cultural practices of sun avoidance, skin coverage, and indoor occupation prevent the cutaneous vitamin D synthesis that is the primary vitamin D source for most of the world’s population outside of northern latitudes where dietary vitamin D fortification has been implemented.
The clinical importance of calcium and vitamin D adequacy for bone health extends across the entire lifespan, with different physiological priorities at different life stages that require age-appropriate nutritional strategies. During childhood and adolescence, adequate calcium and vitamin D intake is essential for achieving the maximal genetic potential for peak bone mass, with each additional standard deviation of peak bone mass achieved during growth associated with approximately fifty percent reduction in the lifetime fracture risk attributable to osteoporosis, making childhood calcium and vitamin D nutrition a primary determinant of lifetime fracture risk that acts decades before the osteoporosis it prevents would have developed. During adulthood and particularly in the postmenopausal and older adult years, adequate calcium and vitamin D intake supports the maintenance of bone density, reduces the parathyroid hormone-driven bone resorption that produces secondary hyperparathyroidism when calcium absorption is insufficient, and optimizes the skeletal response to the pharmacological osteoporosis treatments that require adequate calcium and vitamin D as the nutritional substrate for their bone-protective effects.
Calcium Biology and Dietary Requirements
Calcium is the most abundant mineral in the human body, with approximately ninety-nine percent of the body’s calcium stored in bone and teeth as hydroxyapatite crystals that provide the mineral phase responsible for skeletal rigidity, and the remaining one percent distributed in the plasma and intracellular spaces where it performs the essential signaling functions of neuronal transmission, cardiac electrical conduction, muscle contraction, blood coagulation, and enzyme activation that make calcium the most universally critical mineral in human physiology. The tightly regulated serum calcium concentration, maintained within the narrow range of 2.2 to 2.6 millimoles per liter through the integrated actions of parathyroid hormone, calcitriol, and calcitonin on intestinal absorption, renal tubular reabsorption, and bone mineral mobilization, protects the vital non-skeletal functions of calcium at the cost of skeletal calcium reserves when dietary calcium supply is insufficient to maintain serum calcium through absorption alone.
The intestinal absorption of dietary calcium occurs primarily in the proximal small intestine through both a transcellular active transport mechanism that is stimulated by the active vitamin D metabolite calcitriol and a paracellular passive diffusion mechanism that is proportional to the luminal calcium concentration and operates independently of vitamin D status. The active transcellular transport pathway, involving the sequential actions of the TRPV6 calcium channel at the apical membrane of intestinal enterocytes, the calcium-binding protein calbindin-D9k that facilitates intracellular calcium diffusion, and the plasma membrane calcium ATPase and sodium-calcium exchanger at the basolateral membrane that extrude calcium into the portal circulation, is the primary mechanism for efficient calcium absorption when dietary calcium intake is low and the vitamin D system is fully activated to maximize absorption. This active pathway is therefore most important during periods of physiological calcium demand including growth, pregnancy, and lactation, when calcitriol levels are elevated and the fractional calcium absorption efficiency is maximal, while the paracellular pathway becomes the dominant absorption route at higher calcium intakes when the active pathway is saturated.
The recommended daily calcium intake for bone health varies by age, sex, and physiological state, reflecting the different calcium requirements at different life stages. Adults aged nineteen to fifty require approximately one thousand milligrams of calcium daily, while adults aged fifty-one and older, particularly postmenopausal women whose reduced estrogen impairs both calcium absorption efficiency and renal calcium conservation, require eleven hundred to twelve hundred milligrams daily to maintain calcium balance. The primary dietary sources of calcium in most Western diets are dairy products including milk, yogurt, and cheese, which provide highly bioavailable calcium at relatively modest portion sizes, with fortified plant-based milk alternatives, calcium-set tofu, canned fish with bones, certain green vegetables including kale and broccoli, and fortified orange juice providing important calcium sources for individuals who avoid or are unable to consume dairy. The bioavailability of calcium varies substantially between food sources, with dairy calcium absorbed with approximately thirty to thirty-five percent efficiency, oxalate-rich foods like spinach absorbed with only about five percent efficiency because oxalate forms insoluble calcium complexes that prevent absorption, and most other calcium sources absorbed at intermediate efficiencies.
Calcium supplement use is widespread in older adults as a strategy for achieving recommended intakes when dietary sources are insufficient, but the evidence regarding the cardiovascular safety of calcium supplementation has generated substantial clinical and public health debate that has appropriately complicated supplementation recommendations. Multiple meta-analyses of calcium supplementation trials have suggested a possible modest increase in the risk of myocardial infarction with calcium supplement use, hypothesized to result from the acute calcium load of supplement ingestion producing transient hypercalcemia and accelerated arterial calcification. The clinical significance and causal nature of this association remain contested, with some analyses failing to find an association and with methodological concerns regarding the comparability of supplemented and non-supplemented groups in observational studies. The current clinical consensus, reflected in major osteoporosis guidelines, recommends prioritizing calcium intake from dietary sources, supplementing only the shortfall that cannot be achieved through diet alone rather than the total recommended intake, taking supplement doses split to no more than five hundred milligrams at a time to minimize peak calcium loads, and avoiding excessive supplementation beyond twelve hundred to fifteen hundred milligrams of total daily calcium from all sources.
Vitamin D Physiology and Deficiency Consequences
Vitamin D, despite its designation as a vitamin, functions physiologically as a steroid hormone synthesized in the skin from 7-dehydrocholesterol through a photochemical reaction driven by ultraviolet B radiation, and subsequently activated through sequential hydroxylation steps in the liver to produce 25-hydroxyvitamin D, the major circulating storage form whose measurement reflects vitamin D status, and then in the kidney and other tissues to produce the biologically active metabolite 1,25-dihydroxyvitamin D, also known as calcitriol, that binds to the nuclear vitamin D receptor and regulates the transcription of hundreds of target genes in virtually every tissue of the body. The skeletal actions of calcitriol include the stimulation of intestinal calcium and phosphate absorption, the regulation of osteoblast and osteoclast gene expression, and the maintenance of the mineral ion concentrations in the extracellular fluid that are required for the passive mineralization of newly formed osteoid matrix.
Vitamin D deficiency produces a spectrum of skeletal consequences that range from the subclinical impairment of calcium absorption and secondary hyperparathyroidism that accelerates bone loss in older adults to the clinically overt skeletal disease of rickets in children and osteomalacia in adults, in which the deficiency of calcitriol prevents the normal mineralization of newly formed bone matrix, producing soft, deformable bones in growing children and painful, mechanically weak bones with characteristic pseudofractures on X-ray in affected adults. The secondary hyperparathyroidism that develops as a compensatory response to vitamin D deficiency-induced calcium malabsorption is the primary mediating mechanism through which vitamin D insufficiency accelerates bone loss and increases fracture risk in older adults without producing the more severe skeletal disease of frank osteomalacia, with the elevated parathyroid hormone continuously stimulating osteoclast-mediated bone resorption to mobilize calcium from the skeleton and maintain serum calcium at the cost of bone mineral density.
The vitamin D status of older adults is particularly vulnerable to deficiency through multiple concurrent mechanisms that include reduced cutaneous vitamin D synthesis from both the decreased density of 7-dehydrocholesterol in aging skin and the indoor lifestyle and sun-avoidance behaviors of many elderly individuals, reduced renal 1-alpha-hydroxylase activity that impairs the conversion of 25-hydroxyvitamin D to calcitriol even when circulating 25-hydroxyvitamin D levels are adequate, reduced intestinal vitamin D receptor expression that decreases the intestinal responsiveness to calcitriol-driven calcium absorption stimulation, and the reduced dietary intake of vitamin D-containing foods that frequently accompanies the diminished appetite and restricted dietary variety of aging. The combined impact of these age-related changes in vitamin D metabolism makes supplementation with vitamin D at doses substantially exceeding the dietary reference intake a clinical necessity for the majority of older adults, with most osteoporosis guidelines recommending vitamin D supplementation at eight hundred to two thousand international units daily to maintain serum 25-hydroxyvitamin D above fifty to seventy-five nanomoles per liter in individuals over sixty-five years of age.
Clinical Assessment and Supplementation Strategies
The clinical assessment of calcium and vitamin D nutritional status in patients at risk for osteoporosis requires the systematic evaluation of dietary calcium intake through a structured food frequency questionnaire or dietary history, the measurement of serum 25-hydroxyvitamin D as the most reliable indicator of vitamin D stores, and the assessment of serum calcium, phosphate, and parathyroid hormone to identify the secondary hyperparathyroidism of vitamin D deficiency and the rare cases of hypercalcemia that would contraindicate calcium supplementation. Bone-specific alkaline phosphatase and osteocalcin as markers of bone formation activity, and urinary or serum N-telopeptide or C-telopeptide of type I collagen as markers of bone resorption activity, provide dynamic information about the current rate of bone turnover that complements the static assessment of bone mineral density and helps identify individuals with high bone turnover from secondary hyperparathyroidism who would benefit most urgently from calcium and vitamin D optimization.
The correction of vitamin D deficiency in patients with osteoporosis or high fracture risk may require loading doses that more rapidly restore serum 25-hydroxyvitamin D to optimal concentrations than standard maintenance supplementation, with regimens of fifty thousand international units of vitamin D2 or D3 weekly for eight weeks commonly used to correct deficiency before transitioning to daily maintenance supplementation. Vitamin D3 cholecalciferol is generally preferred over vitamin D2 ergocalciferol for supplementation based on evidence that D3 more effectively raises serum 25-hydroxyvitamin D concentrations and maintains them at higher levels during supplementation, though both forms are effective at correcting deficiency when administered in equivalent doses. The optimization of calcium and vitamin D status is a prerequisite for the effective pharmacological treatment of osteoporosis with bisphosphonates, denosumab, and bone-forming agents, because all of these treatments operate within the context of calcium and vitamin D availability for bone mineral deposition, and inadequate calcium and vitamin D will limit the skeletal response to pharmacological treatment and in the case of parenteral bisphosphonate treatment may precipitate the symptomatic hypocalcemia that is a recognized complication of potent antiresorptive therapy in vitamin D-deficient patients.